These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12856053)

  • 21. Clinical recovery and limited cure in canine visceral leishmaniasis treated with aminosidine (paromomycin).
    Vexenat JA; Olliaro PL; Fonseca de Castro JA; Cavalcante R; Furtado Campos JH; Tavares JP; Miles MA
    Am J Trop Med Hyg; 1998 Apr; 58(4):448-53. PubMed ID: 9574790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous Leishmaniasis in an American Adolescent Returning From Israel.
    Ganjaei KG; Lawton K; Gaur S
    J Pediatric Infect Dis Soc; 2018 Aug; 7(3):e178-e181. PubMed ID: 29878238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis.
    Hepburn NC; Tidman MJ; Hunter JA
    Trans R Soc Trop Med Hyg; 1994; 88(6):700-3. PubMed ID: 7886779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical 15% Paromomycin-Aquaphilic for Bolivian Leishmania braziliensis Cutaneous Leishmaniasis: A Randomized, Placebo-controlled Trial.
    Soto J; Soto P; Ajata A; Luque C; Tintaya C; Paz D; Rivero D; Berman J
    Clin Infect Dis; 2019 Feb; 68(5):844-849. PubMed ID: 30260376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical paromomycin for New World cutaneous leishmaniasis.
    Sosa N; Pascale JM; Jiménez AI; Norwood JA; Kreishman-Detrick M; Weina PJ; Lawrence K; McCarthy WF; Adams RC; Scott C; Ransom J; Tang D; Grogl M
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007253. PubMed ID: 31048871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aminosidine and its combination with sodium stibogluconate in the treatment of diffuse cutaneous leishmaniasis caused by Leishmania aethiopica.
    Teklemariam S; Hiwot AG; Frommel D; Miko TL; Ganlov G; Bryceson A
    Trans R Soc Trop Med Hyg; 1994; 88(3):334-9. PubMed ID: 7974682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of aminosidine (paromomycin) and sodium stibogluconate for treatment of canine leishmaniasis.
    Poli A; Sozzi S; Guidi G; Bandinelli P; Mancianti F
    Vet Parasitol; 1997 Aug; 71(4):263-71. PubMed ID: 9299695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited efficacy of injectable aminosidine as single-agent therapy for Colombian cutaneous leishmaniasis.
    Soto J; Grogl M; Berman J; Olliaro P
    Trans R Soc Trop Med Hyg; 1994; 88(6):695-8. PubMed ID: 7886777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injectable paromomycin for Visceral leishmaniasis in India.
    Sundar S; Jha TK; Thakur CP; Sinha PK; Bhattacharya SK
    N Engl J Med; 2007 Jun; 356(25):2571-81. PubMed ID: 17582067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod.
    El-On J; Bazarsky E; Sneir R
    Exp Parasitol; 2007 Jun; 116(2):156-62. PubMed ID: 17306255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occlusive paromomycin for cutaneous leishmaniasis.
    Bell SA; Schaller M; Röcken M
    Lancet; 1997 Jan; 349(9044):29. PubMed ID: 8988124
    [No Abstract]   [Full Text] [Related]  

  • 32. Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.
    Ben Salah A; Ben Messaoud N; Guedri E; Zaatour A; Ben Alaya N; Bettaieb J; Gharbi A; Belhadj Hamida N; Boukthir A; Chlif S; Abdelhamid K; El Ahmadi Z; Louzir H; Mokni M; Morizot G; Buffet P; Smith PL; Kopydlowski KM; Kreishman-Deitrick M; Smith KS; Nielsen CJ; Ullman DR; Norwood JA; Thorne GD; McCarthy WF; Adams RC; Rice RM; Tang D; Berman J; Ransom J; Magill AJ; Grogl M
    N Engl J Med; 2013 Feb; 368(6):524-32. PubMed ID: 23388004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occlusive paromomycin for cutaneous leishmaniasis.
    Bryceson AD
    Lancet; 1997 May; 349(9063):1477. PubMed ID: 9164342
    [No Abstract]   [Full Text] [Related]  

  • 34. A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis.
    Nassiri-Kashani M; Firooz A; Khamesipour A; Mojtahed F; Nilforoushzadeh M; Hejazi H; Bouzari N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):80-3. PubMed ID: 15649196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran.
    Mohebali M; Fotouhi A; Hooshmand B; Zarei Z; Akhoundi B; Rahnema A; Razaghian AR; Kabir MJ; Nadim A
    Acta Trop; 2007 Jul; 103(1):33-40. PubMed ID: 17586452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
    J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey.
    Ozgoztasi O; Baydar I
    Int J Dermatol; 1997 Jan; 36(1):61-3. PubMed ID: 9071622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study.
    Ben Salah A; Buffet PA; Morizot G; Ben Massoud N; Zâatour A; Ben Alaya N; Haj Hamida NB; El Ahmadi Z; Downs MT; Smith PL; Dellagi K; Grögl M
    PLoS Negl Trop Dis; 2009; 3(5):e432. PubMed ID: 19415122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial.
    Firooz A; Khamesipour A; Ghoorchi MH; Nassiri-Kashani M; Eskandari SE; Khatami A; Hooshmand B; Gorouhi F; Rashighi-Firoozabadi M; Dowlati Y
    Arch Dermatol; 2006 Dec; 142(12):1575-9. PubMed ID: 17178983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study.
    Weinrauch L; Cawich F; Craig P; Sosa JX; el-On J
    J Am Acad Dermatol; 1993 Sep; 29(3):443-6. PubMed ID: 8349861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.